Published in Diabetologia on May 04, 2007
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov (2009) 3.26
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes (2009) 1.65
A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. J Clin Biochem Nutr (2010) 1.63
Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proc Natl Acad Sci U S A (2015) 1.59
Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology (2011) 1.32
Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. J Clin Invest (2011) 1.20
Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor. Diabetes (2012) 1.17
Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice. PLoS One (2011) 1.02
Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist. PLoS One (2012) 0.98
α-cell role in β-cell generation and regeneration. Islets (2012) 0.89
Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion. Endocr Connect (2013) 0.88
Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides. Diabetes (2012) 0.85
Effects of small interfering RNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db/db mice. J Lipid Res (2013) 0.84
Pancreatic alpha-cells from female mice undergo morphofunctional changes during compensatory adaptations of the endocrine pancreas to diet-induced obesity. Sci Rep (2015) 0.80
Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese mice. PLoS One (2012) 0.79
Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus. Diabetes Obes Metab (2016) 0.76
Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis. Int J Exp Pathol (2014) 0.76
Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity. PLoS One (2015) 0.76
An AlphaScreen Assay for the Discovery of Synthetic Chemical Inhibitors of Glucagon Production. J Biomol Screen (2015) 0.75
Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms. World J Diabetes (2014) 0.75
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell (2001) 5.22
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med (1992) 4.37
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27
Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci (2000) 2.12
Islet amyloid and type 2 diabetes mellitus. N Engl J Med (2000) 2.07
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes Obes Metab (2009) 2.04
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci (2002) 2.01
Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90
Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med (1997) 1.84
The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept (2002) 1.82
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76
Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab (1996) 1.76
Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. Br J Surg (2003) 1.74
Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med (2002) 1.74
Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry (1986) 1.57
Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care (2000) 1.54
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Leptin is associated with increased risk of myocardial infarction. J Intern Med (1999) 1.52
Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.51
Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia (2005) 1.51
Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia (1986) 1.49
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2012) 1.49
Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem (2004) 1.47
Prompt epithelial damage and restitution processes in allergen challenged guinea-pig trachea in vivo. Clin Exp Allergy (1997) 1.46
Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes (1998) 1.45
Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. Development (1998) 1.44
In vivo restitution of airway epithelium. Cell Tissue Res (1995) 1.43
A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia (2007) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care (2001) 1.38
Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab (1996) 1.37
Motor responses in rat ileum evoked by nitric oxide donors vs. field stimulation: modulation by pituitary adenylate cyclase-activating peptide, forskolin and guanylate cyclase inhibitors. J Pharmacol Exp Ther (1997) 1.36
Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab (2001) 1.34
Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med (1999) 1.34
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia (1999) 1.34
Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Peptidergic (substance P) nerves in the genito-urinary tract. Neuroscience (1978) 1.31
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes Metab (2012) 1.30
Peptidergic (enkephalin) innervation of the mammalian esophagus. Gastroenterology (1980) 1.27
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27
Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept (1984) 1.26
Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes (1998) 1.25
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology (1985) 1.23
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22
Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol (1998) 1.22
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20
Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res (1977) 1.20
Duodenal endocrine cells in adult coeliac disease. Gut (1979) 1.19
Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries. Neurosci Lett (1985) 1.19
Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol (1985) 1.19
PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest (2000) 1.19
Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res (1983) 1.18
Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: preliminary immunocytochemical observations. Cell Tissue Res (1979) 1.18
Nerve fibers in the gut and pancreas of the rat displaying neuropeptide-Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res (1983) 1.17
Projections of peptide-containing neurons in rat small intestine. Neuroscience (1987) 1.16
Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res (1975) 1.16
Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology (1989) 1.16
Projections of peptide-containing neurons in rat colon. Neuroscience (1988) 1.16
Galanin nerve fibers in the rat gut: distribution, origin and projections. Neuroscience (1985) 1.15
Histamine-producing cells in the stomach and their role in the regulation of acid secretion. Scand J Gastroenterol Suppl (1991) 1.14
Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism (1997) 1.14
Leu-enkephalin-like material in nerves and enterochromaffin cells in the gut. An immunohistochemical study. Histochemistry (1978) 1.14
B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun (1997) 1.13
Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med (1996) 1.13
Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol (1987) 1.12
Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. J Physiol (1976) 1.12
Neuronal VIP in salivary glands: distribution and release. Acta Physiol Scand (1980) 1.11
Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach. Digestion (1986) 1.11
Enteric neuronal plasticity and a reduced number of interstitial cells of Cajal in hypertrophic rat ileum. Gut (1998) 1.11
Galanin: a novel pancreatic neuropeptide. Am J Physiol (1986) 1.11
Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Curr Pharm Des (2001) 1.10
Pancreatic gastrin in foetal and neonatal rats. Nature (1976) 1.10
Distribution, origin and projections of nitric oxide synthase-containing neurons in gut and pancreas. Neuroscience (1994) 1.09
Immunohistochemical localization of neurotensin in endocrine cells of the gut. Cell Tissue Res (1977) 1.09
VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res (1980) 1.08
Topography of somatostatin cells in the stomach of the rat: possible functional significance. Cell Tissue Res (1979) 1.08
Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia (1998) 1.08
Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1988) 1.08
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol (2002) 1.08
Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation. Gastroenterology (1994) 1.08
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism (2004) 1.07
Localization and peptide content of endocrine pancreatic tumors. Ann Surg (1990) 1.07
Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regul Pept (1985) 1.07
Origin and distribution of VIP (vasoactive intestinal polypeptide)-nerves in the genito-urinary tract. Cell Tissue Res (1980) 1.06
Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology (1986) 1.06
A rich VIP nerve supply is characteristic of sphincters. Nature (1979) 1.06
Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil (2009) 1.06
Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol (1988) 1.06